Lotus Ventures Inc. (OTCPK: LTTS.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
Lotus Ventures Inc. (OTCPK: LTTS.F) operates in the Pharmaceuticals industry within the Health Care sector.
Tweenvest scores Lotus Ventures Inc. across four factors: quality 49/100. Its strongest factor is quality.
LTTS.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $1.48M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- —
- Next earnings
- —
About Lotus Ventures Inc.
Lotus Ventures Inc. engages in the production, cultivation, and sale of cannabis products for medical purpose in Canada. The company sells its products under the Lotus Cannabis Co. brand name. Lotus Ventures Inc. was incorporated in 2007 and is based in Vancouver, Canada.
- ISIN
- CA54571Q1081
- Listed since
- Dec 31, 2010
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,205.00 | -2.32% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.60 | -0.93% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.84 | -1.67% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.90 | -1.04% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.60 | -1.73% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.24 | -1.16% |
Figures last refreshed Aug 18, 2026.